Anokion’s $35 Million Equity Funding from Pfizer

Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer.Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance,…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now